Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
TCTR |
Last refreshed on:
|
29 April 2024 |
Main ID: |
TCTR20141127002 |
Date of registration:
|
27/11/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Hypertensive Phase and Its Association with Surgical Failure in Baerveldt Implantation
|
Scientific title:
|
Hypertensive Phase and Its Association with Surgical Failure in Baerveldt Implantation |
Date of first enrolment:
|
19/12/2013 |
Target sample size:
|
|
Recruitment status: |
Completed |
URL:
|
https://www.thaiclinicaltrials.org/show/TCTR20141127002 |
Study type:
|
Observational |
Study design:
|
N/A
|
Phase:
|
N/A
|
|
Contacts
|
Name:
|
Department of Ophthalmology Faculty of Medicine
Chulalongkorn university |
Address:
|
Rama4 road, Patumwan
Bangkok
Thailand |
Telephone:
|
022564142 |
Email:
|
tammapat@gmail.com |
Affiliation:
|
Chulalongkorn university |
|
Name:
|
SUPAWAN
SURUKRATTANASKUL |
Address:
|
162 Puengmee21, Sukumvit road, Banggak Phrakanong
10260
Bangkok
Thailand |
Telephone:
|
0851656117 |
Email:
|
lim_auddy@yahoo.com |
Affiliation:
|
Faculty of Medicine Chulalongkorn university |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: • Glaucoma patients age ≥20 yrs who need surgical treatment by Baerveldt implantation
• Baerveldt implantation by glaucoma specialist in King Chulalongkorn Memorial Hospital since 2004 to present and follow up >=18 months
Exclusion criteria: • Glaucoma patients operated by Baerveldt combined with other procedure such as Trabeculectomy with antimetabolites
• Patient F/U less than 18 months
Age minimum:
20 Years
Age maximum:
80 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Hypertensive Phase Baerveldt implantation
|
Rate of hypertensive phase and its association with surgical failure Hypertensive Phase Baerveldt implantation
|
Intervention(s)
|
Baerveldt implantation patients
|
Glaucoma patients, age > 20 years, with indication for Baerveldt implant, operated in King Chulalongkorn Memorial Hospital since 2004-2014.
|
Treatment
|
Primary Outcome(s)
|
Rate of hypertensive phase 18 months Percent
|
Secondary Outcome(s)
|
Surgical failure 18 months Percent
|
Source(s) of Monetary Support
|
Department of Ophthalmology
|
Ethics review
|
Status: Submitted, approved
Approval date:
Contact:
http://research.md.chula.ac.th
Institutional Review Board
662 256 4493 Ext. 14,15
http://research.md.chula.ac.th
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
24/11/2014 |
URL:
|
|
|
|